期刊文献+

c-kit在血液病中的表达 被引量:2

THE EXPRESSION OF THE PROTO-ONCOGENE(C-KIT) IN MOST KINDS OF HEMATOPATHY
下载PDF
导出
摘要 目的 :探讨原癌基因c -kit在血液病中表达的情况。方法 :用Ficoll分离液分离 ,收集骨髓单个核细胞。c -kit的表达采用RT -PCR法。结果 :在不同血液病中c -kit的表达情况不一 ,在急性髓细胞性白血病 (AML)为 5 7.8% ,急性淋巴细胞性白血病 (ALL)为 8.3 % ,骨髓增生异常综合征 (MDS)为 40 %。结论 :c -kit主要在AML中表达 ,提示c -kit表达是粒细胞的一个特异性标志。 Objective:To investigate the expression of the proto-oncogene,c-kit,in 78 cases with most kinds of hematopathy.Methods:Bone marrow mononuclear cells were obtained from leukaemia patients by Ficoll-Conray density-gradient centrifugation.The expression of c-kit was detected by the reverse transcriptase polymerase chain reaction(RT-PCR).Results:c-kit was found about 57.8% in AML(the diagnosis of leukaemia was established by morphology and cytochemistry according to the French-American-British,FAB and immunologic features), c-kit gene shows a high specificity for AML;whereas the expression of c-kit is low in MDS (40%) ,CML (11.1%) ,ALL (8.3%) ,and absent in CLL,AA,MM,ITP,IDA,etc.Conclusions:The expression of c-kit is high in AML.
出处 《交通医学》 2001年第1期16-17,20,共3页 Medical Journal of Communications
关键词 血液病 C-KIT RT-PCR 基因表达 白血病 Hematopathy c-kit RT-PCR
  • 相关文献

参考文献2

二级参考文献2

共引文献5

同被引文献11

  • 1Lanotte NV, Martin TV, Najman S, et al. NB4 a muturation indueible cell line with t (15;17 ) maker isolated from a human acute promyelocylic leukemia ( M3 ) [ J ]. Blood, 1991,77 ( 5 ) : 1080-1086.
  • 2Kinoshita T, Koike K, Mwamtemi HH, et al. Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors[J]. Blood, 2000,95(9) : 2521-2828.
  • 3Reck R, Bollag W. Potentiation of retinoid-induced differentiation of HL-60 and U937 cells by cylokines [ J]. Eur J Cancer, 1991,27 (1): 53-57.
  • 4Jing YK, Wang L, Xia LJ ,et al. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo[J]. Blood,2001,97( 1 ) : 264-269.
  • 5Stamatoyannopoulos G, Philip W, Roger M, et al. The molecular basis of blood disease (3rd edition) [ M].北京:人民卫生出版社,2001:38.
  • 6Heinrich MC, Blanke CD, Druker BJ, et al. Inhibition of KIT tyrosine kinase activity a novel molecular approach to the treatment of KIT-positive malignancies [ J ]. J Clin Oncol, 2002,20 ( 6 ) : 1692- 1703.
  • 7Xiang Z, Kreisel F,Cain J,et al. Neoplasia driven by mutant c-KIT is mediated by intraeellular, not plasma membrane, receptor signaling[J]. Mol cell boil, 2007 ,27(1 ) :267-282.
  • 8Lu L;Heinrich MC;Wang LS.Retroviral-mediated gene transduction of c-kit into single hematopoietic progenitor cells from cord blood enhances erythroid colony formation and decreases sensitivity to inhibition by tumor necrosis factor-α and transforming growth factor-β1,1999.
  • 9Longley BJ;Reguera MJ;Ma Y.Classed of c-kit activating mutation:proposed mechanisms of action and implications for disease classification and therapy[J],2001.
  • 10Bene MC;Bernier M;Casasnovas RO.The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias,1998.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部